View in EDS

Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy.

Saved in:
Bibliographic Details
Title: Fibroblast growth factor 23 is associated with cardiac disease severity in transthyretin amyloid cardiomyopathy.
Authors: Eslami M; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Ermolaev N; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Kronberger C; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Schmid L; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Poledniczek M; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Gregshammer B; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Kösters A; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Alasti F; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Kammerlander AA; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Rettl R; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Duca F; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Binder C; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Kastner J; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria., Marculescu R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Badr Eslam R; Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria. roza.badreslam@meduniwien.ac.at.; Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria. roza.badreslam@meduniwien.ac.at.
Source: Scientific reports [Sci Rep] 2026 May 04. Date of Electronic Publication: 2026 May 04.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2045-2322
DOI:10.1038/s41598-026-51879-z